Cancer immunotherapy using checkpoint blockade

Cited by (124)

Items 101–124 of 124

1. Identification of TYROBP and C1QB as Two Novel Key Genes With Prognostic Value in Gastric Cancer by Network Analysis
   Jiang, Junjie, Ding, Yongfeng, Wu, Mengjie, Lyu, Xiadong, Wang, Haifeng, Chen, Yanyan, Wang, Haiyong, Teng, Lisong · 2020 · Frontiers in Oncology
2. Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 Interaction for Cancer Immunotherapy
   Yin, Huawu, Zhou, Xiuman, Huang, Yen-Hua, King, Gordon J., Collins, Brett M., Gao, Yanfeng, Craik, David J., Wang, Conan K. · 2021 · Journal of the American Chemical Society
3. Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy
   Ji, Panpan, Sun, Wenqi, Zhang, Siyan, Xing, Yuqi, Wang, Chen, Wei, Mengying, Li, Qiuyun, Ji, Gang, Yang, Guodong · 2023 · Advanced Science
4. Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule
   Berezhnoy, Alexey, Sumrow, Bradley J., Stahl, Kurt, Shah, Kalpana, Liu, Daorong, Li, Jonathan, Hao, Su-Shin, De Costa, Anushka, Kaul, Sanjeev, Bendell, Johanna et al. · 2020 · Cell Reports Medicine
5. Reporting of Immune Checkpoint Inhibitor Therapy–Associated Diabetes, 2015–2019
   Liu, Jiaqing, Zhou, Huaqiang, Zhang, Yaxiong, Fang, Wenfeng, Yang, Yunpeng, Huang, Yan, Zhang, Li · 2020 · Diabetes Care
6. Secretions From Hypochlorous Acid-Treated Tumor Cells Delivered in a Melittin Hydrogel Potentiate Cancer Immunotherapy
   Zhou, Yuhan, Ye, Ting, Ye, Chengzhi, Wan, Chao, Yuan, Siyue, Liu, Yushuai, Li, Tianyu, Jiang, Fagang, Lovell, Jonathan F., Jin, Honglin et al. · 2022 · Bioactive Materials
7. T cells and monocyte-derived myeloid cells mediate immunotherapy-related hepatitis in a mouse model
   Llewellyn, Heather P., Arat, Seda, Gao, Jingjin, Wen, Ji, Xia, Shuhua, Kalabat, Dalia, Oziolor, Elias, Virgen-Slane, Richard, Affolter, Timothy, Ji, Changhua · 2021 · Journal of Hepatology
8. Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two clinical trials
   Mankor, Joanne M., Disselhorst, Maria J., Poncin, Myrthe, Baas, Paul, Aerts, Joachim G.J.V., Vroman, Heleen · 2020 · eBioMedicine
9. Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response
   Kim, Chang Gon, Koh, June-Young, Shin, Su-Jin, Shin, Ji-Hee, Hong, Moonki, Chung, Hyun Cheol, Rha, Sun Young, Kim, Hyo Song, Lee, Choong-Kun, Lee, Ji Hyun et al. · 2023 · Cell Reports Medicine
10. Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1
    Renrick, Ariana N., Thounaojam, Menaka C., de Aquino, Maria Teresa P., Chaudhuri, Evan, Pandhare, Jui, Dash, Chandravanu, Shanker, Anil · 2021 · Frontiers in Immunology
11. Leveraging microenvironmental synthetic lethalities to treat cancer
    Metcalf, Kevin J., Alazzeh, Alaa, Werb, Zena, Weaver, Valerie M. · 2021 · Journal of Clinical Investigation
12. Colorectal Cancer Immunotherapy: State of the Art and Future Directions
    Cornista, Alyssa Mauri, Giolito, Maria Virginia, Baker, Kristi, Hazime, Hajar, Dufait, Inès, Datta, Jashodeep, Khumukcham, Saratchandra Singh, De Ridder, Mark, Roper, Jatin, Abreu, Maria T. et al. · 2023 · Gastro Hep Advances
13. KRAS Mutation Dictates the Cancer Immune Environment in Pancreatic Ductal Adenocarcinoma and Other Adenocarcinomas
    Gu, Meichen, Gao, Yanli, Chang, Pengyu · 2021 · Cancers
14. Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients
    Pirozyan, Mehdi R., McGuire, Helen M., Emran, Abdullah Al, Tseng, Hsin-Yi, Tiffen, Jessamy C., Lee, Jenny H., Carlino, Matteo S., Menzies, Alexander M., Long, Georgina V., Scolyer, Richard A. et al. · 2020 · Frontiers in Immunology
15. Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality
    Guillot, Nicolas, Roméo, Barnabé, Manesh, Shima Sepehri, Milano, Gerard, Brest, Patrick, Zitvogel, Laurence, Hofman, Paul, Mograbi, Baharia · 2023 · Trends in Molecular Medicine
16. Learning from the nexus of autoimmunity and cancer
    Mangani, Davide, Yang, Dandan, Anderson, Ana C. · 2023 · Immunity
17. Sunitinib inhibits PD-L1 expression in osteosarcoma by targeting STAT3 and remodels the immune system in tumor-bearing mice
    Duan, Xian Liang, Guo, Jian Ping, Li, Fan, Xiu, Chao, Wang, Hua · 2020 · Future Oncology
18. The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models <i>In Vivo</i> Reflects a Complex Balance between Tumor-Suppressive and Proprogression Activities of TGFβ
    Yang, Yuan, Yang, Howard H., Tang, Binwu, Wu, Alex Man Lai, Flanders, Kathleen C., Moshkovich, Nellie, Weinberg, Douglas S., Welsh, Michael A., Weng, Jia, Ochoa, Humberto J. et al. · 2020 · Clinical Cancer Research
19. Transient “rest” induces functional reinvigoration and epigenetic remodeling in exhausted CAR-T cells
    Weber, Evan W., Lynn, Rachel C., Parker, Kevin R., Anbunathan, Hima, Lattin, John, Sotillo, Elena, Good, Zinaida, Malipatlolla, Meena, Xu, Peng, Vandris, Panos et al. · 2020
20. Caloric restriction promotes the stemness and antitumor activity of T lymphocytes
    Pietrocola, Federico, Kroemer, Guido · 2019 · OncoImmunology
21. Recruiting Immunity for the Fight against Colorectal Cancer: Current Status and Challenges
    Al-Hujaily, Ensaf M., Al-Sowayan, Batla S., Alyousef, Zeyad, Uddin, Shahab, Alammari, Farah · 2022 · International Journal of Molecular Sciences
22. Effect of Concomitant Use of Proton Pump Inhibitors on Immunotherapy Clinical Response in Advanced Cancer Patients: Real-Life Setting
    Cantarelli, Lorenzo, Gutiérrez Nicolás, Fernando, García Gil, Sara, Morales Barrios, Jose A., Oramas Rodriguez, Juana, Nazco Casariego, Gloria J. · 2024 · Journal of Immunotherapy
23. PathTIGR: A pathway topology-informed graph representation learning framework for immunotherapy response prediction
    Li X, He Y, Wu J, Wang Z, Zhao X, Zhang Y, Pan B, Tang Y, Han J · 2026 · PubMed
24. An immune world model for multiscale forecasting and therapeutic hypothesis generation
    Cui, Taoyong, Wang, Xi, Li, Zonghang, Ding, Jinchao, You, Lingsen, Xu, Yuzhi, Xu, Wanghan, Wu, Fang, Ying, Kejun, Ouyang, Wanli et al. · 2026 · arXiv